The majority of RTT cases are caused by de novo mutations in the X-linked methyl-CpG-binding protein 2 (MECP2) gene, which plays a critical role in normal brain development, specifically in the maturation of the central nervous system (CNS) and synapse development and function (Liyanage and Rastegar, 2014). The gene discussed is MECP2; the disease is Rett syndrome.